- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Two online press releases about investigational ASTX727 were circulated to UK outlets. Panel found misleading, unsubstantiated study claims and failure to maintain…
A senior employee’s LinkedIn comment praising Strivit D3 (“licensed, prescribed, kosher and halal”) was ruled to be public promotion of a prescription-only…
Complaint about Saxenda promotion at a medical aesthetics exhibition. Appeal Board ruled no public promotion (Clause 26.1) and no Clause 2 breach,…
Anonymous NHS intensivist challenged BPL comments in Daily Mail/Telegraph and LinkedIn about unlicensed ‘hyperimmune’ Covid-19 shots. Panel found no breach (narrowly, no…
Employee complaint alleged data concealment and other issues. Panel found breaches only for using two training items outside approval dates and an…
Novartis self-reported after a representative discussed CHMP wording for unlicensed Piqray with two clinicians. Panel ruled this was pre-authorisation promotion and a…
Complaint said an Ozempic promotional email implied use in all type 2 diabetes patients because “adults” appeared later in small text. Panel…
A health professional complained a Beovu journal ad lacked safety information given post-marketing retinal vasculitis/occlusion concerns. Panel found prescribing info covered key…
Employee complaint about Toujeo Coach webinar invite emails (copy/paste template, tracking numbers sent, alleged reminder emails). Panel found no evidence of non-compliance…
Complaint alleged off-licence promotion and inadequate safety info in an Invokana CREDENCE webinar/video. Panel initially found a misleading dosing slide, but Appeal…
Anonymous HCP alleged off-licence promotion after an APC formulary listed Suliqua for use with basal insulin. Panel found no evidence Sanofi influenced…
Teva’s HCP and education websites were ruled promotional in parts. Breaches included missing prominent PI/AE signposting online, missing PI for some products,…
A senior BMS UK employee ‘liked’ a US colleague’s LinkedIn post that linked (via Twitter) to a US press release naming Opdivo…
Lilly alleged Novo Nordisk’s GLP-1RA CVOT slide deck misled HCPs by inviting comparisons and omitting primary vs secondary prevention context. Panel and…
Two AstraZeneca press releases described its COVID-19 vaccine as “safe” and presented efficacy as relative risk reduction without absolute risk context. PMCPA…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.